Open Outbreak

West Nile virus infection

Also known as: West Nile, WNV, West Nile fever

West Nile virus infection is a mosquito-borne disease caused by West Nile virus. Birds are the main hosts in nature, and mosquitoes spread the virus from birds to people, horses, and other animals. Most infected people do not feel ill. WHO says about 80% have no symptoms, while about 20% develop a fever illness. A small minority develop serious infection of the brain or nervous system, such as meningitis or encephalitis, which can be fatal. WHO reports an incubation period of usually 3 to 14 days. People over 50 and some immunocompromised people are at higher risk of severe disease. Human-to-human spread is not the usual route, but infection can rarely occur through blood transfusion, organ transplant, and similar health products. There is no licensed human vaccine, and treatment is supportive rather than a specific antiviral cure. The virus is found across Africa, Europe, the Middle East, North America, and parts of West Asia, and WHO has also documented spread in the Caribbean.

Key facts

TransmissionMainly through bites of infected mosquitoes after bird-mosquito circulation; birds are the main natural hosts. Rarely through blood transfusion, organ transplant, and other human-origin health products. WHO states humans and horses do not transmit the virus to new mosquitoes.
IncubationUsually 3 to 14 days.
Case fatalityUnknown for all infections overall. WHO states about 1 in 150 infected people develop severe neuroinvasive disease. Wikipedia summary says risk of death among those with nervous system involvement is about 10%.
Reproduction numberunknown
VaccineNo vaccine currently exists for humans. Vaccines are available for horses.
TreatmentNo specific antiviral treatment established on the sources used here; care is supportive, especially for neuroinvasive disease.
ReservoirPrimarily birds; migratory birds help spread the virus between regions.
Endemic regionsCommonly found in Africa, Europe, the Middle East, North America, and West Asia; WHO also notes spread throughout the Caribbean.

Transmission

West Nile virus is spread mainly by mosquitoes. WHO says the virus is generally carried by migratory birds, then transmitted locally by mosquitoes to humans, horses, and other mammals. Birds are the key reservoir in nature. Humans and horses are usually considered dead-end hosts, meaning they do not pass enough virus back to mosquitoes to keep the cycle going. This matters because ordinary contact with a sick person is not the main driver of spread. WHO also notes rare non-mosquito routes. These include blood transfusion, organ transplant, and other human-origin health products. The incubation period is usually 3 to 14 days after infection. Because spread depends on mosquitoes and bird activity, risk usually rises in warmer seasons and in places where competent mosquito species are established. For public health, the main practical prevention steps are mosquito control, reducing bites, and watching bird, horse, and mosquito surveillance for signs the virus is circulating.

Symptoms and severity

Most people infected with West Nile virus never notice it. WHO states that about 80% of infected people are asymptomatic. About 20% develop West Nile fever, which can include fever, headache, tiredness, body aches, nausea, vomiting, sometimes a rash on the trunk, and swollen lymph glands. A much smaller share become seriously ill. WHO estimates that about 1 in 150 infected people develop severe disease affecting the nervous system, such as encephalitis, meningitis, or a polio-like paralysis. Reported warning signs include high fever, neck stiffness, confusion, altered mental status, tremors, convulsions, muscle weakness, and paralysis. Serious illness can happen at any age, but WHO says people over 50 and some immunocompromised people, such as transplant recipients, are at highest risk. The encyclopedia summary used here says death occurs in about 10% of patients once the nervous system is affected, but an overall case-fatality rate for all infections is not established in the sources reviewed.

Treatment and vaccines

The sources used here do not show a specific antiviral medicine that is proven and routinely recommended for West Nile virus infection. In practice, care is supportive. That means treating symptoms, giving fluids when needed, and managing complications such as seizures, breathing problems, or brain inflammation in hospital for severe cases. People with mild illness often recover without hospital care, while neuroinvasive disease may need intensive monitoring and rehabilitation. WHO is clear that there is no vaccine currently available for humans. WHO also notes that vaccines are available for horses, which helps animal health but does not directly protect people. Because there is no human vaccine and no specific standard antiviral cure in these sources, prevention depends mostly on avoiding mosquito bites, controlling mosquito populations, and screening blood or transplant products where relevant. For worried readers, the main point is simple: prevention and early supportive medical care matter more than a specific drug or shot, because neither is yet established for routine human use.

Where it occurs

WHO describes West Nile virus as commonly found in Africa, Europe, the Middle East, North America, and West Asia. That broad range reflects the ecology of migratory birds and mosquitoes rather than a single fixed hotspot. The virus can appear in places where it was not previously recognized if infected birds arrive and local mosquitoes can transmit it. WHO notices in this session show that human infection has been documented in different regions over time, including Europe, Brazil, and Barbados. The Barbados notice from 2024 is important because WHO says it was the first detected human case there, and also notes that West Nile virus has spread throughout the Caribbean, likely via infected migratory birds. This does not mean every country has continuous transmission every year, but it does show the virus can establish itself in new settings when ecological conditions allow. Local mosquito surveillance, bird surveillance, and seasonal weather patterns are therefore key to understanding where risk is rising.

Recent history

On this site, the archive lists 8 West Nile events since 1999. The WHO items returned in this session show a scattered but recurring pattern rather than one single continuous emergency. Early archive entries include the 1999 United States event and a 2000 notice from Israel. In 2002, WHO posted multiple updates from the United States and Canada, showing the virus had become a notable public-health issue in North America. Later notices show geographic spread or recognition in additional places. WHO posted a Europe item in 2011, reported the first detected human case in Brazil in 2014, and documented a case in Portugal in 2015. Most recently, WHO reported the first detected human case in Barbados on 2024-10-03. In that notice, WHO judged the current risk from West Nile virus in Barbados to be low, with low risk of international dissemination, while noting the possibility of undetected circulation in birds or horses. Together, these notices suggest repeated seasonal or local events, with occasional appearance in new countries.

What to watch

The main signals that would make West Nile virus more concerning are straightforward. First is spread into new regions or islands, especially places with no previous human cases. WHO's 2024 Barbados notice is a reminder that first detections matter, because they may signal unnoticed circulation in birds and mosquitoes. Second is evidence of sustained local transmission in mosquitoes, birds, horses, or blood donors, because human cases often appear after the virus is already established in the environment. Third is any rise in neuroinvasive disease, severe cases in older adults or immunocompromised people, or increases in deaths. Fourth is any sign that blood-safety or transplant screening is missing infections. Fifth is a change in mosquito control effectiveness, including insecticide resistance, because prevention relies heavily on vector control. Finally, vaccine supply for horses and progress toward a human vaccine matter. WHO states there is still no human vaccine, so any licensed human vaccine or shortage of animal-control tools would change the risk picture.

Updated